The pathogenesis of the meningitis caused by Streptococcus suis: The unresolved questions

Veterinary Microbiology

Volumn 76, Issue 3, 2000, Pages 259-272

  Gottschalk, Marcelo ^a   Segura, Mariela ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Meningitis; Pathogenesis; Review; Streptococcus suis; Virulence factors

Indexed keywords

ADHESIN; CELL PROTEIN; HEMOLYSIN; LYSOZYME;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CELL INTERACTION; MENINGITIS; NONHUMAN; PATHOGENESIS; SERODIAGNOSIS; STREPTOCOCCUS;

ANIMALS; MENINGITIS; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS; SWINE; SWINE DISEASES;

ANIMALIA; BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS SUIS; SUS SCROFA;

EID: 0034307834     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(00)00250-9     Document Type: Article

References (46)

1. Benkirane R., Gottschalk M., Jacques M., Dubreuil J.D. Immunochemical characterization of an IgG-binding protein of Streptococcus suis. FEMS Immunol. Med. Microbiol. 20:1998;121-127.
2. Berthelot-Hérault, F., Morvan, H., Kéribin, A.M., Gottschalk, M., Kobisch, M., 2000. Production of muraminidase-released protein (MRP), extracellular factor (EF) and haemolysin by field isolates of Streptococcus suis capsular types 2, 1/2, 9, 7 and 3 isolated from swine in France. Vet. Res. 31, (in press).
3. Boye M., Feenstra A., Tegtmeier C., Andersen L., Rasmussen S., Bille-Hansen V. Detection of Streptococcus suis by in situ hybridization, indirect immunofluorescence, and peroxidase-antiperoxidase assays in formalin-fixed, paraffin-embedded tissue sections from pigs. J. Vet. Diagn. Invest. 12:2000;224-232.
4. Busque P., Higgins R., Sénéchal S., Marchand R., Quessy S. Simultaneous flow cytometric measurement of Streptococcus suis phagocytosis by polymorphonuclear and mononuclear blood leukocytes. Vet. Microbiol. 63:1998;229-238.
5. Charland N., Kobisch M., Martineau-Doizé B., Jacques M., Gottschalk M. Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2. FEMS Immunol. Med. Microbiol. 14:1996;195-203.
6. Charland N., Jacques M., Lacouture S., Gottschalk M. Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2. Microbiology. 143:1997;3607-3614.
7. Charland N., Harel J., Kobisch M., Lacasse S., Gottschalk M. Streptococcus suis serotype 2 mutants deficient in capsular expression. Microbiology. 144:1998;325-332.
8. Charland N., Nizet V., Rubens C., Kim K., Lacouture S., Gottschalk M. Streptococcus suis interactions with human brain microvascular endothelial cells. Infect. Immun. 68:2000;637-643.
9. Chatellier S., Harel J., Zhang Y., Gottschalk M., Higgins R., Devriese L., Brousseau R. Phylogenetic diversity of Streptococcus suis strains of various serotypes as revealed by 16S rRNA gene sequence comparison. Int. J. Syst. Bacteriol. 48:1998;581-589.
10. Chatellier S., Gottschalk M., Higgins R., Brousseau R., Harel J. Relatedness of Streptococcus suis serotype 2 isolates from different geographical origins as evaluated by molecular fingerprinting and phenotyping. J. Clin. Microbiol. 37:1999;362-366.
11. Cundell D., Gerard N.P., Gerard C., Idanpaan-Helkklla I., Tuamanen E. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature. 377:1995;435-438.
12. Del Campo Sepúlveda E.M., Altman E., Kobisch M., D'Allaire S., Gottschalk M. Detection of antibodies against Streptococcus suis capsular type 2 using a purified capsular polysaccharide antigen-based indirect ELISA. Vet. Microbiol. 52:1996;113-125.
13. Devriese L.A., Ceyssens K., Hommez J., Kilpper-Balz R., Schleifer K.H. Characteristics of different Streptococcus suis ecovars and description of a simplified identification method. Vet. Microbiol. 26:1991;141-150.
14. Gottschalk M., Higgins R., Jacques M., Mittal K.R., Henrichsen J. Description of 14 new capsular types of Streptococcus suis. J. Clin. Microbiol. 27:1989;2633-2636.
15. Gottschalk M., Lacouture S., Dubreuil J.D. Characterization of Streptococcus suis capsular type 2 haemolysin. Microbiology. 141:1995;189-195.
16. Gottschalk M., Lebrun A., Wisselink H., Dubreuil D., Smith H., Vecht U. Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can. J. Vet. Res. 62:1998;75-79.
17. Gottschalk M., Higgins R., Quessy S. Dilemma of the virulence of Streptococcus suis. J. Clin. Microbiol. 37:1999;4202-4203.
18. Gottschalk M., Lacouture S., Odierno L. Immunomagnetic isolation of Streptococcus suis serotypes 2 and 1/2 from swine tonsils. J. Clin. Microbiol. 37:1999;2877-2881.
19. Haataja, S., Tikkanen, K., Hytönen, J., Finne, J., 1996. The Galα1-4Gal-binding adhesin of Streptococcus suis, a Gram-positive meningitis-associated bacterium. In: Kahane, I., Ofek, I. (Eds.), Toward Anti-adhesion Therapy for Microbial Diseases. Adv. Exp. Med. Biol. 408, 25-34.
20. Heath P.J., Hunt B.W., Duff J.P., Wilkinson J.D. Streptococcus suis serotype 14 as a cause of pig disease in the UK. Vet. Rec. 139:1996;450-451.
21. Higgins, R., Gottschalk, M., 1999. Streptococcal diseases. In: Straw, B.E., D'Allaire, S., Mengeling, W.L., Taylor, D.J. (Eds.), Diseases of Swine. Iowa State University Press, Ames, IA, pp. 563-570.
22. Higgins R., Gottschalk M. Distribution of Streptococcus suis capsular types in 1999. Can. Vet. J. 41:2000;414.
23. Higgins R., Gottschalk M., Boudreau M., Lebrun A., Henrichsen J. Description of six new Streptococcus suis capsular types. J. Vet. Diagn. Invest. 7:1995;405-406.
24. Jacobs A.A., Loeffen W., van den Berg A., Storm P. Identification, purification and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis. Infect. Immun. 62:1994;1742-1748.
25. Lalonde M., Segura M., Lacouture S., Gottschalk M. Interactions between Streptococcus suis serotype 2 and different epithelial cell lines. Microbiology. 146:2000;1913-1921.
26. Norton P.M., Rolph C., Ward P.N., Bentley R.W., Leigh J.A. Epithelial invasion and cell lysis by virulent strains of Streptococcus suis is enhanced by the presence of suilysin. FEMS Immunol. Med. Microbiol. 26:1999;25-35.
27. Quessy S., Busque P., Higgins R., Jacques M., Dubreuil J.D. Description of an albumin binding activity for Streptococcus suis serotype 2. FEMS Microbiol. Lett. 147:1997;245-250.
28. Rasmussen S., Andresen O. 16S rDNA sequence variations of some Streptococcus suis serotypes. Int. J. Syst. Bacteriol. 48:1998;1063-1065.
29. Sanford S.E. Gross and histopathological findings in unusual lesions caused by Streptococcus suis in pigs. II. Central nervous system lesions. Can. J. Vet. Res. 51:1987;486-489.
30. Segers R.P., Kenter L., de Haan A., Jacobs A.A. Characterisation of the gene encoding suilysin from Streptococcus suis and expression in field strains. FEMS Microbiol. Lett. 167:1998;255-261.
31. Segura, M., Gottschalk, M., 1999. Adhesion of Streptococcus suis capsular type 2 to phagocytic cells. In: Abstracts of the XIV Lancefield International Symposium on Streptococci and Streptococcal Diseases, Abstract P8.17. Auckland, New Zealand.
32. Segura M., Cléroux P., Gottschalk M. Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages. FEMS Immunol. Med. Microbiol. 21:1998;189-195.
33. Segura M., Stankova J., Gottschalk M. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages. Infect. Immun. 67:1999;4646-4654.
34. Smith H.E., Wisselink H.J., Vecht U., Gielkens A., Smits M.A. High-efficiency transformation and gene inactivation in Streptococcus suis type 2. Microbiology. 141:1995;181-188.
35. Smith H.E., Wisselink H.J., Stockhofe-Zurwieden N., Vecht U., Smits M.A. Virulence markers of Streptococcus suis type 1 and 2. Adv. Exp. Med. Biol. 418:1997;651-656.
36. Smith H.E., Damman M., van der Velde J., Wagenaar F., Wisselink H.J., Stockhofe-Zurwieden N., Smits M.A. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect. Immun. 67:1999;1750-1756.
37. Smith H.E., Veenbergen V., van der Velde J., Damman M., Wisselink H., Smits M.A. The cps genes of Streptococcus suis serotypes 1, 2, and 9: development of rapid serotype-specific PCR assay. J. Clin. Microbiol. 37:1999;3146-3152.
38. Sprenger H., Rösler A., Tonn P., Braune H.J., Huffmann G., Gemsa D. Chemokines in the cerebrospinal fluid of patients with meningitis. Clin. Immunol. Immunopathol. 80:1996;155-161.
39. Staats J.J., Feder I., Okwumabua O., Chengappa M.M. Streptococcus suis: past and present. Vet. Res. Commun. 21:1997;381-407.
40. Staats J., Brandon P., Stewart G., Chengappa M.M. Presence of the Streptococcus suis suilysin gene and expression of MRP and EF correlates with high virulence in Streptococcus suis type 2 isolates. Vet. Microbiol. 70:1999;201-211.
41. St. Geme J. III, Cutter D. Influence of pili, fibrils, and capsule on in vitro adherence of Haemophilus influenzae type b. Mol. Microbiol. 21:1996;21-31.
42. Tuomanen E. Entry of pathogens into the central nervous system. FEMS Microbiol. Rev. 18:1996;289-299.
43. Wekerle, H., 1993. Lymphocyte traffic to the brain. In: Pardridge, W.M. (Ed.), The Blood-brain Barrier. Cellular and Molecular Biology. Raven, New York, pp. 67-85.
44. Wessels M.R., Rubens C.E., Benedi V.J., Kasper D.L. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc. Natl. Acad. Sci. USA. 86:1989;8983-8987.
45. Williams A.E., Blakemore W.E. Pathogenesis of meningitis caused by Streptococcus suis type 2. J. Infect. Dis. 162:1990;474-481.
46. Wilson S., Drevets D.A. Listeria monocytogenes infection and activation of human brain microvascular endothelial cells. J. Infect. Dis. 178:1998;1658-1666.